"FDA issues early alert for Baxter’s Spectrum infusion pump" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in ...

The FDA today issued a notice warning of a potential high-risk issue with certain Baxter Spectrum infusion pump systems.

Baxter International ended 2024 on a positive note, overcoming challenges posed by Hurricane Helene and delivering better-than-expected Q4 results. The success of the Novum IQ infusion pump ...

Baxter Healthcare has issued a recall for some Spectrum infusion pumps due to a potential defect involving missing motor mounting screws, which could lead to interruptions, delays or incorrect dosing ...

The US Food and Drug Administration (FDA) has issued an early alert over a ‘potentially high-risk’ issue with certain Baxter Sigma Spectrum and Spectrum IQ infusion pumps. The agency’s ...

If you recall, Baxter placed a pretty big bet to internally develop a brand new to market and novel infusion pump platform both with the hardware, software and digital platform and we're seeing it ...

Continuing operations exclude Baxter’s Kidney Care business ... portfolio driven by robust sales for the Novum IQ infusion pump, increased sales of parenteral nutrition products and strong ...

Feb 20 (Reuters) - Baxter International (BAX.N), opens new tab on Thursday forecast 2025 profit above Wall Street estimates banking on strong sales of its medical devices, sending the company's ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2024, and provided its ...

Acquisitions: Baxter will focus on fold-in, tuck-in acquisitions in areas such as pharmaceutical injectables, ambulatory pump space, and advanced surgery. Capital Allocation: The company remains ...

Manitoba's cancer authority has stopped using an infusion pump line — made by a company whose IV pumps have been the subject ...